Chalmers, J., Schmitt, J., Apfelbacher, C., Dohil, M., Eichenfield, L., Simpson, E., Singh, J., Spuls, P., Thomas, K., Admani, S., Aoki, V., Ardeleanu, M., Barbarot, S., Berger, T., Bergman, J., Block, J., Borok, N., Burton, T., Chamlin, S., Deckert, S., DeKlotz, C., Graff, L., Hanifin, J., Hebert, A., Humphreys, R., Katoh, N., Kisa, R., Margolis, D., Merhand, S., Minnillo, R., Mizutani, H., Nankervis, H., Ohya, Y., Rodgers, P., Schram, M., Stalder, J., Svensson, A., Takaoka, R., Teper, A., Tom, W., von Kobyletzki, L., Weisshaar, E., Zelt, S., & Williams, H. (n.d.). report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). British journal of dermatology, 171, 1318–1325. http://access.bl.uk/ark:/81055/vdc_100025002921.0x000004